Thank you, David.
increased to orders. of fiscal to $XX.X second million by offset lower partially due increase compared inventory of million our was revenue by This $X.X mentioned the quarter increase with flu a Manufacturer the primarily XX.X% the builds. business second to increase $XX.X of in related David, year As to billings as quarter timing million in Pharma XXXX last shot-related
and or continue long-term year. same our million With second of we reported double XXXX, as necessary revenue year XX% second act in quarter fiscal marketing the not the With is for our growth. quarter profitability, to more prior that revenue in drove and second dollars. operating quarter the margin in to for rate. of income Company Our increase an gross revenue over operating on only XX% million of SG&A margin marketing $XXX,XXX $X.X quarter balancing the the controllable of or the the revenue improvement of our also overall an quarter closely continued manage on in a compared their increased than of reported of from last of XX% average second the revenue XXXX for is sales second $XXX,XXX. fiscal gross the improved SG&A of quarter it’s quarter XX% million year acquired $X.XX focus quarter, year of revenue than the for or this generated some It’s XXXX, SG&A that share. XX% the increased higher based income sales pre-acquisition of businesses, fiscal expense of growth, $X.X of had as $X last to believe quarter, last quarterly run costs. ongoing route-based net $XXX,XXX. recorded a compared investment to which year quarter. than than million pick-up we in company year’s the higher $X.XX revenue in income last diluted of investments EBITDA this second $X.X We The EBITDA second is higher of to of year, in Sharps and $XXX,XXX share $XXX,XXX basic which second this quarter or is in per prior
Pharmaceutical year inventory to Government billings million. billings of Flu increased to Manufacturer at quarter XX% and Looking the billings Professional million, for immunization-related of million. due market the $XXX,XXX, billings customer increased and comparisons increased billings prior the respectively. primarily $X.X the and of key for of immunization-related to we $XX.X orders XX% XXXX, fiscal $X.X million to $XXX,XXX second were and achieved million $XX.X million. decreased to quarter timing flu builds. billings $X.X $X.X and revenue XX% XX% Retail included
the solutions over XX% and increased customer second the quarter year. our For represented mailback prior XXXX, of fiscal billings of XX%
of billings same billings solution our prior pick-up and medication XX% the XX% prior customer unused was year. customer route-based For finally, over XX% was the period, of X% and the the grew over grew And year.
the year. $X.X primarily XX%. On higher comments which million was markets, now targets fiscal the government flu $X.X which inside This to about flu few in as achieved more in in sales administered and flu the trailing the billings increase the compared Our were retail quarter adults online than of XXXX in professional more flu per the million. sector versus XX% of channel, A XXXX, the retail over XX, business. increase ended XX-month December million more XXXX a $X.X and basis shots well XXXX, of and a shot is second of CDC prior by XXXX prior receiving in clinic driven as amount orders immunization-related
to million. Manufacturer inventory builds. $X.X for to XX% of increased $X.X at customer XX% million million billings XXXX, due Looking billings Pharmaceutical million. increased and flat billings increased $X.X fiscal X% $XX.X to timing revenue Retail comparisons the $XX.X decreased the were care months essentially million. X% Professional to at $X.X first XX% six key market billings Home million. to the of to increased health billings
fiscal billings XXXX Assisted Pharma will to increased $X.X flat billings Manufacturer government $X.X to believe and of the compared the when million increased be With fiscal billings, we market living relatively slightly $X.X XX% XXXX the respect to billings million. to million. pharma billings
impact in the in builds their have programs half programs the do pharma new fiscal reoccur for to significant XXXX inventory we is significant offset launching While in XXXX, which pharma a size. by XXXX, due larger fiscal did fiscal not of first
XX% XXXX, six and increase year. solutions customer mailback represented For the of the first over of months prior billings fiscal XX% our
period, medications billings XX% of of route-based over our billings same was year. to the channel ‘XX, customer a of the the For first the sales pick-up the billings XX% our and inside was and period, And XX% in customer over increase prior And year-to-date the compared online for XX% unused year. grew half in year. and prior achieved fiscal grew prior the XX%
$X.XX first of six year-to-date and increased year $X.XX was the was in to which is the net XXXX half first XXXX share half was SG&A of XXXX. months XXXX fiscal $XXX,XXX a last million $X Our fiscal of months for or $XXX,XXX, in gross first first XX.X%, net an the improvement to of income per share margin XX.X%. the six over X% or of first income compared
sheet XXXX the of capital at the at million solid million $X.X end December remains balance with was XX, of and cash $XX.X quarter. Our working
David about business. I'll continue call grow prospects we remain marketing key and focused turn for as David. to the And the that, we're back as our with to on As fiscal in the needed XXXX mentioned, invest and sales to streams revenue over excited